References
Study flowchart of included and excluded patients.PANAS negative and positive aspects, respectively, by groups and moments.Participants’ demographic characteristics.* Others: Bolivia (2), Argentina (1), Spain (1), United States (1), Netherlands (1), Panama (1), Paraguay (1), Peru (1), Portugal (1) and Sweden (1).Characteristics of chemotherapy treatment.PANAS negative and positive aspects comparisons between pre- and post-intervention moments and groups.* Significant Symptoms evaluated by the ESAS: comparisons between pre- and post-intervention moments and groups.* Significant Symptoms evaluated by the ESAS: comparisons between moments and groups, specifying interventions—1st part.* Significant Symptoms evaluated by the ESAS: comparisons between moments and groups, specifying interventions—2nd part.* Significant Summary of clinical improvement observed in each group.